ANTIGENESIS BIOLOGICS LTD
Company Documents
| Date | Description |
|---|---|
| 24/10/2524 October 2025 New | Total exemption full accounts made up to 2025-02-28 |
| 15/08/2515 August 2025 | Statement of capital following an allotment of shares on 2025-08-13 |
| 05/08/255 August 2025 | Sub-division of shares on 2025-08-04 |
| 28/02/2528 February 2025 | Annual accounts for year ending 28 Feb 2025 |
| 05/02/255 February 2025 | Confirmation statement made on 2025-01-31 with updates |
| 23/10/2423 October 2024 | Termination of appointment of Helen Mccarthy as a director on 2024-10-23 |
| 23/10/2423 October 2024 | Certificate of change of name |
| 23/10/2423 October 2024 | Cessation of Helen Mccarthy as a person with significant control on 2024-10-23 |
| 23/10/2423 October 2024 | Cessation of Nicholas Dunne as a person with significant control on 2024-10-23 |
| 23/10/2423 October 2024 | Termination of appointment of Nicholas Dunne as a director on 2024-10-23 |
| 16/10/2416 October 2024 | Notification of Helen Mccarthy as a person with significant control on 2024-10-15 |
| 16/10/2416 October 2024 | Notification of Nicholas Dunne as a person with significant control on 2024-10-15 |
| 16/10/2416 October 2024 | Statement of capital following an allotment of shares on 2024-10-15 |
| 16/10/2416 October 2024 | Certificate of change of name |
| 16/10/2416 October 2024 | Appointment of Professor Nicholas Dunne as a director on 2024-10-15 |
| 01/08/241 August 2024 | Appointment of Prof Helen Mccarthy as a director on 2024-08-01 |
| 01/08/241 August 2024 | Appointment of Mr Terence Hugh Brannigan as a director on 2024-08-01 |
| 05/02/245 February 2024 | Certificate of change of name |
| 01/02/241 February 2024 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company